Viewing Study NCT04797702


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2025-12-26 @ 3:00 AM
Study NCT ID: NCT04797702
Status: UNKNOWN
Last Update Posted: 2021-03-15
First Post: 2021-02-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Glumetinib Combined With Toripalimab in the Treatment of Relapsed or Metastatic Non-small Cell Lung Cancer.
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module